Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Duda

Showing results (31-40 of 338) with videos related to

Pageof 34
Sort By:
Cancer Journal (Sudbury, Mass.)|July 30, 2015
From the Guest Editors: Role of Tumor Microenvironment in Tumor Progression and Treatment Response: A 30 Years' JourneyRakesh K Jain, Dai Fukumura, Dan G Duda
JAMA Oncology|October 22, 2020
The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma: A ReviewMatthias Pinter, Rakesh K Jain, Dan G Duda
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2009
Biomarkers of antiangiogenic therapy: how do we move from candidate biomarkers to valid biomarkers?Dan G Duda, Marek Ancukiewicz, Rakesh K Jain
Cancer Research|May 3, 2019
Role of Apelin in Glioblastoma Vascularization and Invasion after Anti-VEGF Therapy: What Is the Impact on the Immune System?Zohreh Amoozgar, Rakesh K Jain, Dan G Duda
Angiogenesis|April 1, 2017
Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?Rakesh R Ramjiawan, Arjan W Griffioen, Dan G Duda
Disease Models & Mechanisms|March 5, 2009
Visualizing anti-tumor immune responses in vivoJean Y Perentes, Dan G Duda, Rakesh K Jain
The Journal of Physical Chemistry. C, Nanomaterials and Interfaces|July 7, 2023
Why Sonochemistry in a Thin Layer? Constructive InterferenceDaniel L Parr Iv, Chester G Duda, Johna Leddy
Circulation Research|August 28, 2020
Going Beyond VEGF Pathway Inhibition for Antiangiogenic Cancer Therapy: Is Inhibition of the PP2A/B55α Complex the Answer?John D Martin, Dan G Duda, Rakesh K Jain
Biomedizinische Technik. Biomedical Engineering|January 1, 1990
[Analysis of construction related wear characteristics of different hip joint endoprostheses]G Duda, H J Eng, L Münter, et al.
Terapevticheskii Arkhiv|January 1, 1985
[Various problems of chronopharmacology and chronotherapy at present]R M Zaslavskaia, I Kh Olevskiĭ, S G Duda
Pageof 34

Showing results (31-40 of 338) with videos related to

Sort By:
Pageof 34
Cancer Journal (Sudbury, Mass.)|July 30, 2015
From the Guest Editors: Role of Tumor Microenvironment in Tumor Progression and Treatment Response: A 30 Years' JourneyRakesh K Jain, Dai Fukumura, Dan G Duda
JAMA Oncology|October 22, 2020
The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma: A ReviewMatthias Pinter, Rakesh K Jain, Dan G Duda
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2009
Biomarkers of antiangiogenic therapy: how do we move from candidate biomarkers to valid biomarkers?Dan G Duda, Marek Ancukiewicz, Rakesh K Jain
Cancer Research|May 3, 2019
Role of Apelin in Glioblastoma Vascularization and Invasion after Anti-VEGF Therapy: What Is the Impact on the Immune System?Zohreh Amoozgar, Rakesh K Jain, Dan G Duda
Angiogenesis|April 1, 2017
Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?Rakesh R Ramjiawan, Arjan W Griffioen, Dan G Duda
Disease Models & Mechanisms|March 5, 2009
Visualizing anti-tumor immune responses in vivoJean Y Perentes, Dan G Duda, Rakesh K Jain
The Journal of Physical Chemistry. C, Nanomaterials and Interfaces|July 7, 2023
Why Sonochemistry in a Thin Layer? Constructive InterferenceDaniel L Parr Iv, Chester G Duda, Johna Leddy
Circulation Research|August 28, 2020
Going Beyond VEGF Pathway Inhibition for Antiangiogenic Cancer Therapy: Is Inhibition of the PP2A/B55α Complex the Answer?John D Martin, Dan G Duda, Rakesh K Jain
Biomedizinische Technik. Biomedical Engineering|January 1, 1990
[Analysis of construction related wear characteristics of different hip joint endoprostheses]G Duda, H J Eng, L Münter, et al.
Terapevticheskii Arkhiv|January 1, 1985
[Various problems of chronopharmacology and chronotherapy at present]R M Zaslavskaia, I Kh Olevskiĭ, S G Duda
Pageof 34